Tenderwize
Back to tender search

Open house discount agreements Erythropoietin zeta

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2027 · 290 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Erythropoietin zeta, ATC B03AX01

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume is provided. It is impossible to assess the potential revenue from this agreement.

This is an open-house model, not a standard procurement. The buyer states it is not subject to procurement law. Legal r...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Non-exclusive discount agreements for the pharmaceutical product Erythropoietin zeta (ATC B03AX01) in Germany (Bavaria region).
  • Contracts are for two years from 01.08.2025 to 31.07.2027.
Show full summary

This is an open-house model (not a standard procurement procedure) by AOK Bayern for non-exclusive discount agreements on the active substance Erythropoietin zeta (ATC B03AX01). Any interested pharmaceutical company meeting the eligibility criteria can join. Contracts run from 01.08.2025 to 31.07.2027. No estimated value is provided. Submission is via paper or electronic qualified signature. The procedure is open to all qualified pharmaceutical companies.

Risks

No estimated value or volume is provided. It is impossible to assess the potential revenue from this agreement.

This is an open-house model, not a standard procurement. The buyer states it is not subject to procurement law. Legal r...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Must submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Contracts must be signed and submitted in two copies if by paper, or electronically with qualified electronic signature.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; all eligible companies are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house discount agreements Erythropoietin zeta

Non-exclusive discount agreements for Erythropoietin zeta (ATC B03AX01). Contracts are identical and non-negotiable. The lot covers the entire scope of the open-house model.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2025 - Jul 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; all eligible companies are accepted.

Deadline

Deadline Jun 03, 2027

Procurement Details

Publication date
15 Jun 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
385986-2025

Documents (2)

Similar tenders